JNCE

Jounce Therapeutics, Inc. Common Stock

$22.45 +$0.69 +3.07%



Shares Bought7
Shares Sold7
Total14
Shares Owned0
Last Price$22.45
Total Return-$2.60
Range Today$20.90 - $23.07
52 Week Range$11.05 - $29.29
Open$22.50
Market Cap$700.85M
Volume/Average354.75K/182.23K
P/E Ratio-
Dividend/Yield-




Jounce Therapeutics, Inc. develops and manufactures drugs and immunotherapies. It produces cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber and Padmanee Sharmain in 2013 and is headquartered in Cambridge, MA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
17-10-02 14:22 17-10-02 18:03 $17.03 $17.32 +$0.29 +1.70% sohardtokill1
17-10-02 18:19 17-10-03 15:34 $17.21 $16.26 -$0.95 -5.51% crizisaround unholyurinal
17-10-02 14:26 17-10-03 14:55 $17.10 $16.40 -$0.70 -4.09% sohardtokill1
17-10-02 14:29 17-10-03 14:53 $17.12 $16.40 -$0.72 -4.20% crizisaround sohardtokill1
17-10-02 14:25 17-10-02 18:08 $17.10 $17.35 +$0.25 +1.46% sohardtokill1
17-10-02 18:17 17-10-03 15:33 $17.27 $16.26 -$1.01 -5.84% crizisaround unholyurinal
17-10-02 14:24 17-10-02 18:06 $17.16 $17.40 +$0.24 +1.40% sohardtokill1